CytoMed (GDTC) Director Buys $150K, Part of $300K Cluster
CytoMed Therapeutics Ltd (NASDAQ: GDTC) just posted its second insider purchase in under a week, and the pattern is starting to look like more than coincidence. On July 20, 2026, Choo Chee Kong, who serves as both a Director and a 10%+ owner of the company, bought 100,000 shares on the open market at $1.50 … Read more